Literature DB >> 8543418

Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy.

P Kullavanijaya1, V Rojanavanich.   

Abstract

BACKGROUND: Many methods and medications had been tried for the treatment of chromoblastomycosis with unsatisfactory results. Recently, there were several reports showing a good response of chromoblastomycosis to itraconazole, but it took as long as 18-30 months for lesions to heal.
METHODS: Itraconazole, 200 to 400 mg/day alone or in combination with monthly liquid nitrogen cryotherapy, was tried on 10 cases of chromoblastomycosis, caused by Fonsecaea pedrosoi in order to increase the potency of the drug and shorten the duration of treatment.
RESULTS: The 10 cases included five newly diagnosed and five recalcitrant cases. Two patients were cured by 200 mg/day alone within 3 months. Seven patients required itraconazole, 400 mg/day, with combined cryotherapy to cure the lesions within 5 to 10 months. One case showed marked improvement but no cure. After the period of 1-year follow-up, only one case had a recurrent infection.
CONCLUSIONS: Itraconazole was highly effective and may be useful in the treatment of chromoblastomycosis. A high dose is indicated in chronic fibrotic lesions in combination with liquid nitrogen cryotherapy, with higher efficacy and quicker healing than with medication alone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543418     DOI: 10.1111/j.1365-4362.1995.tb04404.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  5 in total

Review 1.  Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.

Authors:  M Haria; H M Bryson; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

2.  Auricular chromoblastomycosis: a case report and review of published literature.

Authors:  Katlein França; Ricardo Tadeu Villa; Viviane Reis de Azevedo Bastos; Ana Carolina C Almeida; Katyane Massucatti; Daniella Fukumaru; Valcinir Bedin
Journal:  Mycopathologia       Date:  2011-02-17       Impact factor: 2.574

3.  Subcutaneous Mycoses in Travelers.

Authors:  Andrés Tirado-Sánchez; Carlos Franco-Paredes; Alexandro Bonifaz
Journal:  Curr Trop Med Rep       Date:  2020-11-06

4.  Chromoblastomycosis in Western Thailand.

Authors:  Philip McDaniel; Douglas S Walsh
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

Review 5.  Chromoblastomycosis.

Authors:  Paweł M Krzyściak; Małgorzata Pindycka-Piaszczyńska; Michał Piaszczyński
Journal:  Postepy Dermatol Alergol       Date:  2014-10-22       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.